News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

YM BioSciences US unit cleared to start phase II trial of brain cancer drug


Posted on: 08/31/2007

YM BioSciences US unit cleared to start phase II trial of brain cancer drug
08.31.07, 3:45 AM ET

 

LONDON (Thomson Financial) - Oncology company YM BioSciences Inc said the US Food and Drug Administration cleared the company's US unit YM BioSciences USA Inc to start a phase II trial of its cancer drug, nimotuzumab, for an inoperable, treatment-resistant brain cancer in pediatric patients.

The company said the global development program for nimotuzumab includes ongoing and planned clinical trials in Canada, Europe, Japan, Korea, Singapore, India, Argentina, and Brazil.


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740